BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 38747001)

  • 21. Network-based approach to identify prognosis-related genes in tamoxifen-treated patients with estrogen receptor-positive breast cancer.
    Wang Y; Gong X; Zhang Y
    Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34406386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune-related IncRNA LINC00944 responds to variations in ADAR1 levels and it is associated with breast cancer prognosis.
    de Santiago PR; Blanco A; Morales F; Marcelain K; Harismendy O; Sjöberg Herrera M; Armisén R
    Life Sci; 2021 Mar; 268():118956. PubMed ID: 33383047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive analysis of the value of RAB family genes in prognosis of breast invasive carcinoma.
    Lin S; Cao C; Meng Y; Wu P; Gao P; Zhi W; Peng T; Wu P; Gui L
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32432324
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibroblast growth factor receptor-1 protein expression is associated with prognosis in estrogen receptor-positive/human epidermal growth factor receptor-2-negative primary breast cancer.
    Tomiguchi M; Yamamoto Y; Yamamoto-Ibusuki M; Goto-Yamaguchi L; Fujiki Y; Fujiwara S; Sueta A; Hayashi M; Takeshita T; Inao T; Iwase H
    Cancer Sci; 2016 Apr; 107(4):491-8. PubMed ID: 26801869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic and Predictive Impact of Beta-2 Adrenergic Receptor Expression in HER2-Positive Breast Cancer.
    Caparica R; Richard F; Brandão M; Awada A; Sotiriou C; de Azambuja E
    Clin Breast Cancer; 2020 Jun; 20(3):262-273.e7. PubMed ID: 32229175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SOX4 overexpression is a novel biomarker of malignant status and poor prognosis in breast cancer patients.
    Song GD; Sun Y; Shen H; Li W
    Tumour Biol; 2015 Jun; 36(6):4167-73. PubMed ID: 25592378
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comprehensive Analysis of the Expression, Prognosis, and Immune Infiltrates for Chromodomain-Helicase-DNA-Binding Proteins in Breast Tumor.
    Hasanlu M; Amiri-Dashatan N; Farahani M; Koushki M; Ahmadi H; Parsamanesh N; Ahmadi NA
    Asian Pac J Cancer Prev; 2024 May; 25(5):1547-1558. PubMed ID: 38809626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients.
    He JR; Li D; Zhang QX; Liu T; Ding Y; Wu CY; Chen SS; Chen JL
    Aging (Albany NY); 2023 Nov; 15(22):13265-13286. PubMed ID: 37988189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic value of the ubiquitin ligase carboxyl terminus of the Hsc70-interacting protein in postmenopausal breast cancer.
    Kurozumi S; Yamaguchi Y; Hayashi S; Hiyoshi H; Suda T; Gohno T; Matsumoto H; Takei H; Horiguchi J; Takeyoshi I; Oyama T; Kurosumi M
    Cancer Med; 2016 Aug; 5(8):1873-82. PubMed ID: 27334118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of the GTPase IMAP family as an immune-related prognostic biomarker in the breast cancer tumor microenvironment.
    Huo X; Shen G; Li J; Wang M; Xie Q; Zhao F; Ren D; Dong Q; Zhao J
    Gene; 2022 Feb; 812():146094. PubMed ID: 34896519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between HER2 Expression and Clinicopathological Features of Breast Cancer: A Cross- Sectional Study in Vietnam.
    Dang Cong T; Nguyen Thanh T; Nguyen Phan QA; Hoang Thi AP; Nguyen Tran BS; Nguyen Vu QH
    Asian Pac J Cancer Prev; 2020 Apr; 21(4):1135-1142. PubMed ID: 32334482
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bromodomain 4 is a potent prognostic marker associated with immune cell infiltration in breast cancer.
    Zhong L; Yang Z; Lei D; Li L; Song S; Cao D; Liu Y
    Basic Clin Pharmacol Toxicol; 2021 Jan; 128(1):169-182. PubMed ID: 32799413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer.
    Song C; Shang F; Tu W; Liu X
    BMC Cancer; 2023 Mar; 23(1):296. PubMed ID: 37004015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deciphering the nexus between the tumor immune microenvironment and DNA methylation in subgrouping estrogen receptor-positive breast cancer.
    Chen XQ; Zhang F; Xiao FH; Peng Y
    Breast Cancer; 2021 Nov; 28(6):1252-1260. PubMed ID: 33966175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. lncRNA TCL6 correlates with immune cell infiltration and indicates worse survival in breast cancer.
    Zhang Y; Li Z; Chen M; Chen H; Zhong Q; Liang L; Li B
    Breast Cancer; 2020 Jul; 27(4):573-585. PubMed ID: 31960363
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration.
    Liu S; Foulkes WD; Leung S; Gao D; Lau S; Kos Z; Nielsen TO
    Breast Cancer Res; 2014 Sep; 16(5):432. PubMed ID: 25193543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LEP as a potential biomarker in prognosis of breast cancer: Systemic review and meta analyses (PRISMA).
    Jin TY; Saindane M; Park KS; Kim S; Nam S; Yoo Y; Yang JH; Yun I
    Medicine (Baltimore); 2021 Aug; 100(33):e26896. PubMed ID: 34414945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative hormone receptor (HR) expression and gene expression analysis in HR+ inflammatory breast cancer (IBC) vs non-IBC.
    Iwase T; Harano K; Masuda H; Kida K; Hess KR; Wang Y; Dirix L; Van Laere SJ; Lucci A; Krishnamurthy S; Woodward WA; Layman RM; Bertucci F; Ueno NT
    BMC Cancer; 2020 May; 20(1):430. PubMed ID: 32423453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer.
    Magnusson K; Gremel G; Rydén L; Pontén V; Uhlén M; Dimberg A; Jirström K; Pontén F
    BMC Cancer; 2016 Nov; 16(1):904. PubMed ID: 27863473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Establishing the role of BRCA1 in the diagnosis, prognosis and immune infiltrates of breast invasive cancer by bioinformatics analysis and experimental validation.
    Li L; Li S; Zhang X; Mei L; Fu X; Dai M; Wei N
    Aging (Albany NY); 2024 Jan; 16(2):1077-1095. PubMed ID: 38224491
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.